Literature DB >> 35230731

Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review.

Kyungah Suh1, Isaac Kyei1, David S Hage1.   

Abstract

Antibody-based therapeutic agents and other biopharmaceuticals are now used in the treatment of many diseases. However, when these biopharmaceuticals are administrated to patients, an immune reaction may occur that can reduce the drug's efficacy and lead to adverse side-effects. The immunogenicity of biopharmaceuticals can be evaluated by detecting and measuring antibodies that have been produced against these drugs, or antidrug antibodies. Methods for antidrug antibody detection and analysis can be important during the selection of a therapeutic approach based on such drugs and is crucial when developing and testing new biopharmaceuticals. This review examines approaches that have been used for antidrug antibody detection, measurement, and characterization. Many of these approaches are based on immunoassays and antigen binding tests, including homogeneous mobility shift assays. Other techniques that have been used for the analysis of antidrug antibodies are capillary electrophoresis, reporter gene assays, surface plasmon resonance spectroscopy, and liquid chromatography-mass spectrometry. The general principles of each approach will be discussed, along with their recent applications with regards to antidrug antibody analysis.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  Antidrug antibodies; Binding assay; Biopharmaceuticals; Immunogenicity; Monoclonal antibodies

Mesh:

Substances:

Year:  2022        PMID: 35230731      PMCID: PMC9520450          DOI: 10.1002/jssc.202200112

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.614


  112 in total

1.  An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen.

Authors:  Aaron Patton; Michael C Mullenix; Steven J Swanson; Eugen Koren
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

2.  Nanobodies - from llamas to therapeutic proteins.

Authors: 
Journal:  Drug Discov Today Technol       Date:  2010

3.  Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists.

Authors:  Christophe Lallemand; Nadia Kavrochorianou; Casper Steenholdt; Klaus Bendtzen; Mark A Ainsworth; Jean-Francois Meritet; Brigitte Blanchard; Pierre Lebon; Peter Taylor; Peter Charles; Saba Alzabin; Michael G Tovey
Journal:  J Immunol Methods       Date:  2011-09-03       Impact factor: 2.303

4.  Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testing.

Authors:  Theo Rispens; Henk de Vrieze; Els de Groot; Diana Wouters; Steven Stapel; Gerrit J Wolbink; Lucien A Aarden
Journal:  J Immunol Methods       Date:  2011-10-01       Impact factor: 2.303

5.  Novel bioanalytical method for the characterization of the immune response directed against a bispecific F(ab) fragment.

Authors:  Olaf Broders; Uwe Wessels; Markus Zadak; Roland Beckmann; Kay Stubenrauch
Journal:  Bioanalysis       Date:  2020-04-30       Impact factor: 2.681

6.  Antibody response to infliximab and its impact on pharmacokinetics can be transient.

Authors:  Niels Vande Casteele; Ann Gils; Sharat Singh; Linda Ohrmund; Scott Hauenstein; Paul Rutgeerts; Séverine Vermeire
Journal:  Am J Gastroenterol       Date:  2013-02-19       Impact factor: 10.864

Review 7.  Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies.

Authors:  Pauline A van Schouwenburg; Simone Kruithof; Christian Votsmeier; Karin van Schie; Margreet H Hart; Rob N de Jong; Esther E L van Buren; Marieke van Ham; Lucien Aarden; Gertjan Wolbink; Diana Wouters; Theo Rispens
Journal:  J Biol Chem       Date:  2014-10-17       Impact factor: 5.157

8.  Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serum.

Authors:  Barry D Hock; Stewart M Smith; Christopher J McEntyre; Judith L McKenzie; Christiaan Sies; Paula E Keating
Journal:  J Immunol Methods       Date:  2019-09-13       Impact factor: 2.303

9.  Isotyping and Semi-Quantitation of Monkey Anti-Drug Antibodies by Immunocapture Liquid Chromatography-Mass Spectrometry.

Authors:  Xiaoxiao Huang; Xiaobin Xu; Michael A Partridge; Jihua Chen; Ellen Koehler-Stec; Giane Sumner; Haibo Qiu; Albert Torri; Ning Li
Journal:  AAPS J       Date:  2021-01-06       Impact factor: 4.009

Review 10.  Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity.

Authors:  Kathleen P Pratt
Journal:  Antibodies (Basel)       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.